{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:01:51Z","timestamp":1789056111506,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Obstetrics and Gynecology, University of Malaya","award":["UMSCOG\/RF00062017\/01"],"award-info":[{"award-number":["UMSCOG\/RF00062017\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antenatal corticosteroids (ACS) are increasingly used to improve prematurity-related neonatal outcome. A recognized and common adverse effect from administration of antenatal corticosteroid is maternal hyperglycemia. Even normal pregnancy is characterized by relative insulin resistance and glucose intolerance. Treatment of maternal hyperglycemia after ACS might be indicated due to the higher risk of neonatal acidosis which may coincide with premature birth. Metformin is increasingly used to manage diabetes mellitus during pregnancy as it is effective and more patient friendly. There is no data on prophylactic metformin to maintain euglycemia following antenatal corticosteroids administration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A double blind randomized trial. 103 women scheduled to receive two doses of 12-mg intramuscular dexamethasone 12-hour apart were separately randomized to take prophylactic metformin or placebo after stratification according to their gestational diabetes (GDM) status. First oral dose of allocated study drug was taken at enrolment and continued 500\u00a0mg twice daily for 72 hours if not delivered. Six-point blood sugar profiles were obtained each day (pre- and two-hour post breakfast, lunch and dinner) for up to three consecutive days. A hyperglycemic episode is defined as capillary glucose fasting\/pre-meal\u2009\u2265\u20095.3 mmol\/L or two-hour post prandial\/meal\u2009\u2265\u20096.7 mmol\/L. Primary outcome was hyperglycemic episodes on Day-1 (first six blood sugar profile points) following antenatal corticosteroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Number of hyperglycemic episodes on the first day were not significantly different (mean\u2009\u00b1\u2009standard deviation) 3.9\u2009\u00b1\u20091.4 (metformin) vs. 4.1\u2009\u00b1\u20091.6 (placebo) <jats:italic>p<\/jats:italic>\u2009=\u20090.64. Hyperglycemic episodes markedly reduced on second day in both arms to 0.9\u2009\u00b1\u20091.0 (metformin) vs. 1.2\u2009\u00b1\u20091.0 (placebo) <jats:italic>p<\/jats:italic>\u2009=\u20090.15 and further reduced to 0.6\u2009\u00b1\u20091.0 (metformin) vs. 0.7\u2009\u00b1\u20091.0 (placebo) <jats:italic>p<\/jats:italic>\u2009=\u20090.67 on third day. Hypoglycemic episodes during the 3-day study period were few and all other secondary outcomes were not significantly different.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In euglycemic and diet controllable gestational diabetes mellitus women, antenatal corticosteroids cause sustained maternal hyperglycemia only on Day-1. The magnitude of Day-1 hyperglycemia is generally low. Prophylactic metformin does not reduce antenatal corticosteroids\u2019 hyperglycemic effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The trial is registered in the ISRCTN registry on May 4 2017 with trial identifier <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"https:\/\/doi.org\/10.1186\/ISRCTN10156101\">10.1186\/ISRCTN10156101<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-03628-5","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T15:51:38Z","timestamp":1613577098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-2357","authenticated-orcid":false,"given":"Jesrine Gek Shan","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng Chiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maherah","family":"Kamarudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Zawiah","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"3628_CR1","doi-asserted-by":"crossref","unstructured":"Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006(3):CD004454.","DOI":"10.1002\/14651858.CD004454.pub2"},{"key":"3628_CR2","first-page":"CD004454","volume":"3","author":"D Roberts","year":"2017","unstructured":"Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"3628_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","volume":"374","author":"C Gyamfi-Bannerman","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311\u201320.","journal-title":"N Engl J Med"},{"issue":"11","key":"3628_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S2352-4642(19)30292-5","volume":"3","author":"CA Crowther","year":"2019","unstructured":"Crowther CA, Ashwood P, Andersen CC, Middleton PF, Tran T, Doyle LW, et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019;3(11):769\u201380.","journal-title":"Lancet Child Adolesc Health"},{"key":"3628_CR5","unstructured":"Gunasegaran S, Kalavathy S, Lim NL, Jamil MA, Cheah IGS, Ravicahndran J, et al. Guideline on the use of Antenatal Corticosteroids to Prevent Respiratory Distress Syndrome: Academy of Medicine, Malaysia (General Guidelines); 2001 [Available from: http:\/\/www.acadmed.org.my\/index.cfm?&menuid=28."},{"issue":"5","key":"3628_CR6","first-page":"273","volume":"9","author":"J Star","year":"2000","unstructured":"Star J, Hogan J, Sosa ME, Carpenter MW. Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis. J Matern Fetal Med. 2000;9(5):273\u20137.","journal-title":"J Matern Fetal Med"},{"issue":"5 Suppl","key":"3628_CR7","first-page":"1256S-61S","volume":"71","author":"NF Butte","year":"2000","unstructured":"Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(5 Suppl):1256S-61S.","journal-title":"Am J Clin Nutr"},{"key":"3628_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.diabres.2016.06.005","volume":"118","author":"JA Jolley","year":"2016","unstructured":"Jolley JA, Rajan PV, Petersen R, Fong A, Wing DA. Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes. Diabetes Res Clin Pract. 2016;118:98\u2013104.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"3628_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1034\/j.1600-0412.2002.810906.x","volume":"81","author":"ER Mathiesen","year":"2002","unstructured":"Mathiesen ER, Christensen AB, Hellmuth E, Hornnes P, Stage E, Damm P. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]. Acta Obstet Gynecol Scand. 2002;81(9):835\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"3628_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1464-5491.2003.00853.x","volume":"20","author":"K Kaushal","year":"2003","unstructured":"Kaushal K, Gibson JM, Railton A, Hounsome B, New JP, Young RJ. A protocol for improved glycaemic control following corticosteroid therapy in diabetic pregnancies. Diabet Med. 2003;20(1):73\u20135.","journal-title":"Diabet Med"},{"issue":"1","key":"3628_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1471-0528.1982.tb04630.x","volume":"89","author":"GF Lawrence","year":"1982","unstructured":"Lawrence GF, Brown VA, Parsons RJ, Cooke ID. Feto-maternal consequences of high-dose glucose infusion during labour. Br J Obstet Gynaecol. 1982;89(1):27\u201332.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4 Pt 1","key":"3628_CR12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0002-9378(87)80075-3","volume":"157","author":"EH Philipson","year":"1987","unstructured":"Philipson EH, Kalhan SC, Riha MM, Pimentel R. Effects of maternal glucose infusion on fetal acid-base status in human pregnancy. Am J Obstet Gynecol. 1987;157(4 Pt 1):866\u201373.","journal-title":"Am J Obstet Gynecol"},{"issue":"8282","key":"3628_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S0140-6736(82)92227-9","volume":"1","author":"NB Kenepp","year":"1982","unstructured":"Kenepp NB, Kumar S, Shelley WC, Stanley CA, Gabbe SG, Gutsche BB. Fetal and neonatal hazards of maternal hydration with 5\u2009% dextrose before caesarean section. Lancet. 1982;1(8282):1150\u20132.","journal-title":"Lancet"},{"issue":"6","key":"3628_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/01.AOG.0000128045.50439.89","volume":"103","author":"SG Gabbe","year":"2004","unstructured":"Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol. 2004;103(6):1229\u201334.","journal-title":"Obstet Gynecol"},{"key":"3628_CR15","doi-asserted-by":"crossref","unstructured":"Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30 Suppl 2:S251-60.","DOI":"10.2337\/dc07-s225"},{"key":"3628_CR16","unstructured":"National Institute for H. Clinical Excellence ap. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period."},{"key":"3628_CR17","doi-asserted-by":"crossref","unstructured":"Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58 Suppl 1:31 \u2013 9; discussion 75\u201382.","DOI":"10.2165\/00003495-199958001-00009"},{"key":"3628_CR18","doi-asserted-by":"crossref","unstructured":"Hyer S, Balani J, Shehata H. Metformin in Pregnancy: Mechanisms and Clinical Applications. Int J Mol Sci. 2018;19(7).","DOI":"10.3390\/ijms19071954"},{"issue":"3","key":"3628_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humrep\/deh109","volume":"19","author":"CJ Glueck","year":"2004","unstructured":"Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004;19(3):510\u201321.","journal-title":"Hum Reprod"},{"issue":"6","key":"3628_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953\u201366.","journal-title":"Cell Metab"},{"key":"3628_CR21","unstructured":"(MoH) MoHM MM. Management of Diabetes in Pregnancy: Malaysia Health Technology Assessment Section (MaHTAS); 2017."},{"key":"3628_CR22","doi-asserted-by":"crossref","unstructured":"American Diabetes A 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S165-S72.","DOI":"10.2337\/dc19-S014"},{"issue":"1","key":"3628_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"International Hypoglycaemia Study G","year":"2017","unstructured":"International Hypoglycaemia Study G. Glucose Concentrations of Less Than 3.0 mmol\/L (54\u00a0mg\/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155\u20137.","journal-title":"Diabetes Care"},{"key":"3628_CR24","unstructured":"Information NCfB. Metformin hydrochloride compound summary PubChem. 2019."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T15:58:56Z","timestamp":1613577536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3628"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03628-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the ethical standards of Medical Ethics Committee of University Malaya Medical Centre (Date of approval: April 5 2017, Reference number: 20161019-4384) and registered in ISRCTN registry on May 4 2017 (trial identifier: ) prior to enrolment of trial participants. The study was conducted in compliance with the Declaration of Helsinki. Informed written consent was obtained from all trial participants. This article does not contain any studies with animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}